Joint disorders (osteoarthritis, arthritis) 2023, highlighting a significant and broad-based rise in investment, particularly in core health services and prevention, although this growth is slower than that of GDP. Between 2022 and 2023, Italy has witnessed a population, with over one in three Italians (36%) living with at least one chronic condition, according to data from the UniSalute Health Observatory. The most widespread chronic disease is arterial hypertension, affecting one in five Italians (20%), followed by allergic conditions include osteoporosis (7%), diabetes (5%), Between 2017 and 2023, public healthcare spending in Italy increased across most functions. Chronic diseases significantly increase healthcare costs in Italy. In fact, while chronic patients represent Spending on healthcare for curative and rehabilitative purposes grew from E67 billion to E75 billion, only about 30% of the population, they account for over 70% of healthcare spending. As the number of (+11.8%), while ancillary health care services increased from E9 billion to 12 billion (+31.1%). Expenditure on pharmaceuticals and other medical devices went from E18 billion to E20 billion (+14.5%). Disease up to over E42,oo0 for those with four or more chronic illnesses. The aging Italian population and prevention services, despite a decline in 2023 compared to 2022, were still up from E5 billion to E8 billion delayed disease detection further exacerbate this financial burden, posing a serious challenge to the sustainability of the national health system.